Use

This DNA‑based assay detects mutations in exon 12 of the JAK2 gene, useful for diagnosing myeloproliferative neoplasms, particularly in patients negative for the more common JAK2 V617F variant. It aids in confirming diagnoses such as polycythemia vera in V617F‑negative cases.